• Search & Evaluation
  • Deal-structuring & Negotiations
  • Buy & Sell assets

Our suite of intelligent products

A unique and powerful platform for molecule & portfolio valuation, exchanging molecules and drug by optimizing your deal.

Molecule IQ™

  • Know what your molecule is worth
  • Tools for researching and identifying the right drug assets
    that fits your portfolio
  • Knowledge engine for Molecule Exchange and
    Drug Leader Board

Molecule Exchange™

  • Two-sided exchange powering the transfer of drug assets & IP
  • Structured and optimized deal-making with full transparency and collaboration
  • Matching & connecting buyers & sellers to drive strategy
  • Portfolio optimization based on prevailing market conditions

Centralized Zillow like Portal

Unified platform for in- and out-licensing, collaboration, partnering & acquisition

Advanced Valuation Tools

Dynamic comprehensive valuation driving insights from market trends and policy changes

Market Insights and Deal Outcomes

Business impact and post-mortem analysis

Portfolio Optimzation

Actionable insights affecting asset value, portfolio value & market size

Benefits of the
Integrated Suite

  • Simple to use

    Streamlined process for deal-making

  • Proprietary valuation
    methodology

    Real-time, dynamic valuation tools for better accuracy

  • Extensive visibilty into
    dynamic market conditions

    Current information on policy changes and market conditions impacting the business and portfolio

  • Enhancing Search & Evaluation
    and Business Development

    Resources for finding the right assets and establishing the right deal structure

Benefits of the
Integrated Suite

Deal information on public and private biopharma companies


5000 +

Number of drug assets available for partnering


30000 +

Attenuate average deal-making
fees by


95%